Product ID: SQMIG35A2399
Report ID:
SQMIG35A2399 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
63 |
Figures:
75
North America stands as the dominant market for neurological biomarkers. North America's dominance can be attributed to the presence of well-established healthcare infrastructure, extensive research and development activities, and a high prevalence of neurological disorders in the region. Additionally, strong support from government and private organisations for innovative biomarker research and adoption further contributes to North America's leading position in the market.
On the other hand, the fastest-growing region in the global neurological biomarkers market is the Asia-Pacific region. The Asia-Pacific region has been witnessing a significant increase in neurological disorders and a growing demand for advanced diagnostic and therapeutic solutions. Factors such as the rising geriatric population, changing lifestyle habits, and increasing awareness about neurological disorders are driving the adoption of neurological biomarkers in the region. Additionally, investments in healthcare infrastructure and research capabilities are fostering the development and utilisation of biomarkers in clinical diagnostics and drug development. As a result, the Asia-Pacific region is experiencing rapid growth in the neurological biomarkers market.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35A2399